Brian Piekos Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity

KALV Quotes by TradingView

Brian Piekos is Chief Financial Officer of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 10,529 shares of KALV, which is worth approximately $140,246. The most recent transaction as insider was on Nov 24, 2025, when has been sold 4,471 shares (Common Stock) at a price of $13.45 per share, resulting in proceeds of $60,134. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.5K
n/a 3M change
n/a 12M change
Total Value Held $140,246

Brian Piekos Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 24 2025
SELL
Open market or private sale
$60,134 $13.45 p/Share
4,471 Reduced 29.81%
10,529 Common Stock
Nov 21 2025
BUY
Exercise of conversion of derivative security
-
15,000 Added 50.0%
15,000 Common Stock

Also insider at

AMAG
AMAG PHARMACEUTICALS, INC.
Chief Financial Officer
GMTX
Gemini Therapeutics, Inc. Healthcare
CFO
ANGN
Angion Biomedica Corp. Healthcare
Chief Financial Officer
BP

Brian Piekos

Chief Financial Officer
Waltham, MA

Track Institutional and Insider Activities on KALV

Follow KalVista Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

News

Receive news related to KalVista Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KALV